The MoU is set to build a long-term research and academic collaboration spanning discovery science, clinical studies and training. The partnership’s first major initiative will focus on triple-negative breast cancer, aiming to accelerate translational research and improve treatment strategies for one of the most aggressive cancer subtypes.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/9FpajHh
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment